Amarin

6 Healthcare Stocks With Pending August Catalysts
Seeking Alpha
Wed, 08/1/12 - 10:08 am
Abbott Labs
Amgen
Amarin
Arena Pharmaceuticals
Gilead
JNJ
Pfizer
Horizon Pharma
Vivus
Regeneron
Sanofi
Talon Therapeutics
Amarin falls 11% on insider stock-sale reports
Marketwatch
Tue, 07/31/12 - 07:17 pm
Amarin
fish oil
Vascepa
Buy, Sell, or Hold: Amarin
Motley Fool
Sun, 07/29/12 - 12:14 pm
Amarin
Amarin Falls After U.S. Approval Limits Debut Drug’s Use
Bloomberg
Fri, 07/27/12 - 12:17 pm
Amarin
FDA
Vascepa
Amarin Wins Approval For Debut Drug To Treat High Blood Fats
Bloomberg
Thu, 07/26/12 - 10:50 pm
Amarin
FDA
fish oil
AMR101
Vascepa
AMRN FDA Approval Likely Today
Forbes
Thu, 07/26/12 - 10:09 am
FDA
Amarin
AMR101
fish oil
Will the FDA Approve Amarin's AMR101?
Motley Fool
Wed, 07/25/12 - 11:15 pm
fish oil
FDA
AMR101
Amarin
Obesity, Heart Disease And Diabetes - A Biotech Triumvirate To Profit From Healthcare Mega-Trends In The Medium Term
Seeking Alpha
Wed, 07/25/12 - 09:38 am
obesity
heart disease
diabetes
Amarin
MannKind
Arena Pharmaceuticals
Amarin, Horizon Pharma Build Momentum as Drug Approvals Near
Minyanville
Tue, 07/24/12 - 10:12 am
Amarin
AMR101
Horizon Pharma
FDA
rheumatoid arthritis
Lovaza
28 Drugs Facing FDA Approval in 2012-2013
TheStreet.com
Tue, 07/24/12 - 09:52 am
FDA
Amarin
Horizon Pharma
Salix
Progenics Pharmaceuticals
Regeneron
Sanofi
Talon Therapeutics
Gilead
Pfizer
Ironwood
Celgene
NPS Pharmaceuticals
Navidea Biopharmaceuticals
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Amarin Shares Trade Higher on Hope for Fish-Oil Drug
Minyanville
Fri, 07/20/12 - 10:33 am
AMR-101
Amarin
fish oil
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Sun, 07/15/12 - 11:22 am
Alkermes
Medivation
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Questcor Pharmaceuticals
Arena Pharmaceuticals
Seattle Genetics
Incyte
United Therapeutics
Amarin
ONYX Pharmaceuticals
Pharmacyclics
Human Genome Sciences
Theravance
June Meeting Between Amarin and FDA May Have Decided Fate of Fish-Oil Pill
TheStreet.com
Wed, 07/11/12 - 09:29 am
FDA
Amarin
AMR101
Vivus, Onyx, Amarin Await Key Dates in July
Minyanville
Tue, 07/3/12 - 11:43 am
Amarin
ONYX Pharmaceuticals
Vivus
Qnexa
AMR101
Arcalyst
Regeneron
Kyprolis
Salix
Relistor
Progenics Pharmaceuticals
Rayos
Roche
Lucentis
Horizon Pharma
The $150 Million Patent
Motley Fool
Fri, 06/29/12 - 11:59 am
patents
AMR101
Amarin
GSK
Par Pharmaceutical
Teva Pharmaceuticals
Amarin shares jump on positive patent news
Reuters
Wed, 06/27/12 - 10:40 am
patents
Amarin
AMR101
Former Drug Developer Discovers Next-Generation Biotech Stocks
Motley Fool
Sat, 06/23/12 - 11:52 am
Amarin
Ironwood Pharmaceuticals
Medivation
4 Companies With Upcoming Drug Approval Dates With 1 Potential Buyout Looming
Seeking Alpha
Fri, 06/15/12 - 10:10 am
Onyx
Carfilzomib
Arena Pharmaceuticals
lorcaserin
Vivus
Qnexa
AMR101
Amarin
Obagi Medical Products
Amarin's Chart And Background Are Indicating A Jump On The Horizon
Seeking Alpha
Tue, 06/12/12 - 06:45 pm
Amarin
GSK
AMR101

Pages